Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin‐induced asthma
- 1 September 1997
- Vol. 52 (9) , 895-900
- https://doi.org/10.1111/j.1398-9995.1997.tb01248.x
Abstract
We performed a double‐blind, crossover, placebo‐controlled study on the effect of fluticasone propionate (FP) treatment on chronic eosinophilic rhinosinusitis in 15 patients with aspirin‐induced asthma (AIA). There were 10 women and five men aged 32–60 years; average: 45 years. After a 10‐day run‐in period, patients underwent two 4‐week treatment courses (FP vs placebo), separated by a 2‐week washout interval. Clinical activity of FP was evaluated by daily measurement of peak nasal inspiratory flow (PNIF) and a scoring system of subjective symptoms. Nasal challenges with L‐lysine aspirin, using active anterior rhinomanometry, were performed at the entry and on the last day of each treatment period. Weekly mean values of symptom scores were generally lower and PNIF measurements higher during treatment with FP than with placebo. This difference was statistically significant for most recorded parameters for the whole 4‐week FP treatment. On average, the reactions evoked by aspirin nasal challenge were significantly shorter and milder after treatment with FP than with placebo. In 8/13 patients, FP completely prevented aspirin‐precipitated nasal reaction, whereas protection after placebo was observed in only 2/12 subjects (P=0.004). We conclude that intranasal FP is an effective therapy for chronic eosinophilic rhinitis in patients with AIA.Keywords
This publication has 26 references indexed in Scilit:
- Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cellsLife Sciences, 1996
- Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patientsClinical and Experimental Allergy, 1996
- Challenge tests in nose and bronchi: pharmacological modulation of rhinitis and asthmaClinical and Experimental Allergy, 1996
- The rationale for use of topical corticosteroids in allergic rhinitisClinical and Experimental Allergy, 1996
- Fluticasone propionate aqueous nasal spray: a well-tolerated and effective treatment for children with perennial rhinitisPediatric Allergy and Immunology, 1996
- Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthmaJournal of Allergy and Clinical Immunology, 1994
- Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challengeClinical and Experimental Allergy, 1994
- Mast cells and mediators in the nasal mucosa after allergen challenge. Effects of four weeks' treatment with topical glucocorticoidClinical and Experimental Allergy, 1993
- Topical glucocorticoids inhibit activation by allergen in the upper respiratory tractJournal of Allergy and Clinical Immunology, 1992
- Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.BMJ, 1975